Login / Signup

Letter to the Editor: The Hepa 1-6 may not be suitable for use in hepatocellular carcinoma models to explore responses to drug therapy.

Taicheng LuJingzhi ZhangHaiming LiGuangda LiXiaohui YinJingwen YuYingying ZhengZishen LiuYue WangDong ChenYuancan PanTongjing DingYutong ZhangZhengzheng YangZichun YuanGanlin ZhangQingsheng FanXiaoming Wang
Published in: Hepatology (Baltimore, Md.) (2023)
Keyphrases
  • emergency department
  • adverse drug
  • stem cells
  • mesenchymal stem cells